BD Diagnostics, a segment of BD (Becton, Dickinson, and Company), announces that it has received 510(k) clearance from the FDA for the BD ProbeTec Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay.
Read MoreB-R-A-H-M-S Aktiengesellschaft announces that it has submitted 510(k) file to the FDA to market its patented B-R-A-H-M-S MR-proANP Kryptor Test.
Read More
Diagnosing One of the World’s Deadliest Diseases
Read MoreBD Diagnostics, a segment of BD, announces it has received clearance from the FDA to market the BD GeneOhm Cdiff molecular assay for the rapid detection of the Toxin B gene found in toxigenic Clostridium difficile.
Read MoreOrtho Clinical Diagnostics announced 510(k) clearance from the United States Food and Drug Administration (U.S. FDA) for its VITROS 3600
Read More